Bevacizumab in Treating Young Patients With Refractory Solid Tumors

This study has been completed.

Study NCT00085111 Information provided by National Cancer Institute (NCI)

First Received: June 10, 2004 Last Updated: December 14, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2005 (Final data collection date for primary outcome measure)

Publications:

Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ; Children's Oncology Group Study. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20;26(3):399-405.

Glade-Bender JL, Adamson PC, Baruchel S, et al.: A phase I study of bevacizumab in children with refractory solid tumors: a Children's Oncology Group study. [Abstract] J Clin Oncol 24 (Suppl 18): A-9017, 506s, 2006.